Brazilian footballers and the self-report of medicine intake: The show must go on
DOI:
https://doi.org/10.6063/motricidade.40570Keywords:
athletes, non-steroidal anti-inflammatory drugs, doping in sports, football, drug utilizationAbstract
Athletes, especially footballers, frequently use non-steroidal anti-inflammatory drugs (NSAIDs) and other medications. However, limited research on prolonged usage exists, particularly among Brazilian athletes. This study aims to investigate the prevalence of NSAIDs and analgesics in Brazilian footballers, comparing their use with that of athletes from Olympic and Paralympic sports, considering sex, competition period (in or out-of-competition), and sport type (contact or non-contact). An observational study analyzed 8,997 Doping Control Forms from 2021 and 2022, managed by the Brazilian National Anti-Doping Organization. Data such as sport, sex, collection period, and self-reported medication use in the preceding week were extracted. Medications were categorized into five groups: no medication, non-selective NSAIDs, selective NSAIDs (Cox-2), analgesics/myorelaxants, and paracetamol/dipyrone. χ2 tests compared athlete groups, medication use, sex, sport, and test period at a 95% significance level. Results showed higher NSAID usage among footballers compared to Olympic and Paralympic athletes and athletes in contact and non-contact sports. In-competition periods were a significant factor, with footballers showing increased NSAID use compared to other athletes.
Downloads
Published
Issue
Section
License
The authors of submitted manuscripts must transfer the full copyright to Journal Motricidade / Sílabas Didáticas Editions. Granting copyright permission allows the publication and dissemination of the article in printed or electronic formats, and copyrights start at the moment the manuscript is accepted for publication. It also allows Journal Motricidade to use and commercialise the article in terms of licensing, lending or selling its content to indexation/abstracts databases and other entities.
According to the terms of the Creative Commons licence, authors may reproduce a reasonable number of copies for personal or professional purposes, but without any economic gain. SHERPA/RoMEO allows authors to post a final digital copy (post-printing version) of the article on their websites or on their institutions' scientific repository.
